Dr Mary Njeri Wanjau

Postdoctoral Research Fellow, Cancer Health Economics
MaryWanjau
What inspires me

Reach and impact. Conducting research that informs the identification and prioritisation of evidence-based health policies and interventions.

Profile information

Areas of expertise

Economic evaluations, health impact assessment, obesity, non-communicable diseases, cancers

Overview

Dr Mary Njeri Wanjau is a Postdoctoral Research Fellow, Cancer Health Economics at the Viertel Cancer Research Centre, Cancer Council Queensland. Prior to beginning her work in public health and economics research, Dr Wanjau worked for 12 years in the development and management of health promotion programs. Dr Wanjau’s research has focused on the health and economic impact, and the cost-effectiveness of health policies aimed at reducing population level exposure to health risk factors associated with non-communicable disease. This has included physical inactivity, alcohol consumption, diet, overweight and obesity. In her role at Cancer Council Queensland, Dr Wanjau focuses on evaluating the cost-effectiveness of health interventions that seek to improve cancer prevention and risk reduction, access and participation in cancer screening, prevention of cancer-related morbidity and improving quality of life for those experiencing cancer.

Education

PhD (Public Health) | Griffith University 

Master of Arts in Project Planning and Management | The University of Nairobi, Kenya 

Bachelor of Science (Nursing) | The University of Nairobi, Kenya

Get to know Dr Mary Njeri Wanjau

How does your research contribute to the bigger picture in cancer prevention, treatment, and support?

My current role as Postdoctoral Research Fellow, Cancer Health Economics allows me to evaluate the cost-effectiveness of health interventions that seek to improve cancer prevention and risk reduction, screening, treatment and support. Our research quantifies the costs and benefits of health interventions, providing much needed evidence that policymakers can use to guide their decisions and priorities on implementing interventions and policies for cancer risk reduction, screening, treatment and support.

What recent breakthroughs or advances in cancer research are you most excited about?

I am excited to witness the changing perceptions of cancer, often driven by improved knowledge. It is inspiring to see individuals, communities, and cultures engaging with the science of cancer prevention and risk reduction, participating in screening, uptake of treatment and support. On cancer risk reduction, I am encouraged by governments and policymakers taking action to create and protect healthy living environments through various health policies and regulations. While much more can and should be done, I applaud nations and states that prioritise public health, and I hope my research findings can support their efforts.